These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3189324)

  • 1. Characteristics of nephritogenic IgA immune complexes.
    Rifai A
    Am J Kidney Dis; 1988 Nov; 12(5):402-5. PubMed ID: 3189324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of complement activation by human IgA immune complexes.
    Imai H; Chen A; Wyatt RJ; Rifai A
    Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
    Chen A; Wong SS; Rifai A
    Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.
    Rifai A; Millard K
    Clin Exp Immunol; 1985 May; 60(2):363-8. PubMed ID: 3891168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of IgA-containing circulating immune complexes.
    Hebert LA
    Am J Kidney Dis; 1988 Nov; 12(5):388-92. PubMed ID: 3055964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental IgA nephropathy.
    Rifai A; Small PA; Teague PO; Ayoub EM
    J Exp Med; 1979 Nov; 150(5):1161-73. PubMed ID: 159331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of polymeric IgA in complement-mediated solubilization of IgG and IgA immune complexes.
    Schena FP; Pastore A; Montinaro V
    Am J Kidney Dis; 1988 Nov; 12(5):433-6. PubMed ID: 3055971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgA-concanavalin A complexes].
    Davin JC; Dechenne C; Mahieu PR
    Nephrologie; 1989; 10(3):151-5. PubMed ID: 2691913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
    Hashimoto A; Suzuki Y; Suzuki H; Ohsawa I; Brown R; Hall S; Tanaka Y; Novak J; Ohi H; Tomino Y
    Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition.
    Ma Y; Chen L; Xu Y; Han Q; Yu B; Zhao J; Hua Z; Yang Y; Chen J; Han F
    Appl Immunohistochem Mol Morphol; 2020; 28(10):e87-e93. PubMed ID: 31789820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

  • 17. Glomerular disease: sugars and immune complex formation in IgA nephropathy.
    Barratt J; Eitner F
    Nat Rev Nephrol; 2009 Nov; 5(11):612-4. PubMed ID: 19855421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double immunofluorescence studies on IgA-associated immune-complexes in glomerular deposits in patients with IgA nephropathy.
    Tomino Y; Nomoto Y; Endoh M; Sakai H; Arimori S
    Tokai J Exp Clin Med; 1980 Apr; 5(2):147-9. PubMed ID: 6998050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired solubilization of glomerular immune deposits by sera from patients with IgA nephropathy.
    Tomino Y; Sakai H; Suga T; Miura M; Kaneshige H; Endoh M; Nomoto Y
    Am J Kidney Dis; 1983 Jul; 3(1):48-53. PubMed ID: 6191566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.
    González-Cabrero J; Egido J; Barat A; González E
    Immunology; 1990 Jul; 70(3):296-302. PubMed ID: 2379938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.